GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eco Animal Health Group PLC (LSE:EAH) » Definitions » ROE %

Eco Animal Health Group (LSE:EAH) ROE % : -3.17% (As of Sep. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Eco Animal Health Group ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Eco Animal Health Group's annualized net income for the quarter that ended in Sep. 2023 was £-2.61 Mil. Eco Animal Health Group's average Total Stockholders Equity over the quarter that ended in Sep. 2023 was £82.40 Mil. Therefore, Eco Animal Health Group's annualized ROE % for the quarter that ended in Sep. 2023 was -3.17%.

The historical rank and industry rank for Eco Animal Health Group's ROE % or its related term are showing as below:

LSE:EAH' s ROE % Range Over the Past 10 Years
Min: -1.96   Med: 6.73   Max: 12.01
Current: -1.96

During the past 13 years, Eco Animal Health Group's highest ROE % was 12.01%. The lowest was -1.96%. And the median was 6.73%.

LSE:EAH's ROE % is ranked worse than
63.7% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 4.225 vs LSE:EAH: -1.96

Eco Animal Health Group ROE % Historical Data

The historical data trend for Eco Animal Health Group's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eco Animal Health Group ROE % Chart

Eco Animal Health Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.11 5.13 9.43 -0.84 1.22

Eco Animal Health Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.50 -0.16 3.19 -0.76 -3.17

Competitive Comparison of Eco Animal Health Group's ROE %

For the Drug Manufacturers - Specialty & Generic subindustry, Eco Animal Health Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eco Animal Health Group's ROE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eco Animal Health Group's ROE % distribution charts can be found below:

* The bar in red indicates where Eco Animal Health Group's ROE % falls into.



Eco Animal Health Group ROE % Calculation

Eco Animal Health Group's annualized ROE % for the fiscal year that ended in Mar. 2023 is calculated as

ROE %=Net Income (A: Mar. 2023 )/( (Total Stockholders Equity (A: Mar. 2022 )+Total Stockholders Equity (A: Mar. 2023 ))/ count )
=1.008/( (82.064+83.27)/ 2 )
=1.008/82.667
=1.22 %

Eco Animal Health Group's annualized ROE % for the quarter that ended in Sep. 2023 is calculated as

ROE %=Net Income (Q: Sep. 2023 )/( (Total Stockholders Equity (Q: Mar. 2023 )+Total Stockholders Equity (Q: Sep. 2023 ))/ count )
=-2.614/( (83.27+81.521)/ 2 )
=-2.614/82.3955
=-3.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Sep. 2023) net income data. ROE % is displayed in the 30-year financial page.


Eco Animal Health Group  (LSE:EAH) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-2.614/82.3955
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-2.614 / 76.018)*(76.018 / 118.329)*(118.329 / 82.3955)
=Net Margin %*Asset Turnover*Equity Multiplier
=-3.44 %*0.6424*1.4361
=ROA %*Equity Multiplier
=-2.21 %*1.4361
=-3.17 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-2.614/82.3955
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-2.614 / -1.252) * (-1.252 / -1.168) * (-1.168 / 76.018) * (76.018 / 118.329) * (118.329 / 82.3955)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 2.0879 * 1.0719 * -1.54 % * 0.6424 * 1.4361
=-3.17 %

Note: The net income data used here is two times the semi-annual (Sep. 2023) net income data. The Revenue data used here is two times the semi-annual (Sep. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Eco Animal Health Group ROE % Related Terms

Thank you for viewing the detailed overview of Eco Animal Health Group's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Eco Animal Health Group (LSE:EAH) Business Description

Traded in Other Exchanges
N/A
Address
78 Coombe Road, New Malden, London, Surrey, GBR, KT3 4QS
Eco Animal Health Group PLC is engaged in the manufacture and marketing of animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The geographical segments of the company include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World.

Eco Animal Health Group (LSE:EAH) Headlines

No Headlines